A project study on the analysis of rheumatoid arthritis patients at Dhaka Medical College in Bangladesh

Author : Adity Bhowmik, Suvasish Das

The objective of this study is to observe patients profile of Rheumatoid arthritis (RA) at Dhaka Medical College Hospital, Bangladesh. When comes patients profile of any disease , it indicates various features like patient demographics, duration of disease, nature of complications, food habit, family history, past history of patients, and treatment options etc. This prospective study was carried out in Dhaka Medical College Hospital in Dhaka District from 1st August 2014 to 16th August 2014. In this hospital in Dhaka District, provided with questionnaire sheets as a representative of the survey, a total 17 questionnaire were processed for patient survey and total of 150 questionnaire sheets for the patient survey were considered. In Dhaka Medical College Hospital in Dhaka District, interviewed registered physician they are all specialized individual sectors and they are responsible for patient healthcare service. The feature of Rheumatoid Arthritis (RA) patients described as 87% and other diseased patients were 13%. RA diseased patients were treated by some medicines in which some of the medicines were similar and some were dissimilar. Used medicines were Steroid (31%), DMRD (25%), NSAID (13%), Immunosuppressant (12%), TNF Alfa inhibitors (11%), others (8%), respectively. Among those RA patients, 20% needed surgery (joint replacement, tendon repair) and 80% was treated by only drugs. Rheumatoid arthritis (RA) is a chronic systemic disease affecting joints as well as extra-articular structures and is the most common type of inflammatory arthritis worldwide. The enquiry of Rheumatoid Arthritis patient was done by well-organized surveillance. All of these data were beneficial for practical knowledge of Rheumatoid arthritis.

Full Text Attachment

Creative Commons License World Journal of Pharmaceutical Science is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at Permissions beyond the scope of this license may be available at